Evidence map›Paper›PMID 42275295›Full record

ArticleAngewandte Chemie (International ed. in English)2026

Distinct Oxidoreductases Orchestrate Indolethiophene Skeleton Formation and N-Hydroxylation-Mediated Bioactivation in Thienoxidolin Biosynthesis.

Yuanyuan Shi, Xiongfang Zhao, Ziwei Pang, Xintong Zhang, Yunying Xie, Shanshan Chang, Xingxing Li, Yihong Li, Xiaorui Li, Xiumin Zhang and 2 more

Abstract read
In one paragraph

Article in Angewandte Chemie (International ed. in English), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Yuanyuan ShiCAMS Key Laboratory of Synthetic Biology For Drug Innovation, NHC Key Laboratory of Biotechnology for Microbial Drugs, State Key Laboratory of Bioactive Substances and Functions of Natural Medicines, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
Xiongfang ZhaoCAMS Key Laboratory of Synthetic Biology For Drug Innovation, NHC Key Laboratory of Biotechnology for Microbial Drugs, State Key Laboratory of Bioactive Substances and Functions of Natural Medicines, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
Ziwei PangDepartment of Biochemistry, University of Oxford, Oxford, UK.
Xintong ZhangCAMS Key Laboratory of Synthetic Biology For Drug Innovation, NHC Key Laboratory of Biotechnology for Microbial Drugs, State Key Laboratory of Bioactive Substances and Functions of Natural Medicines, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
Yunying XieCAMS Key Laboratory of Synthetic Biology For Drug Innovation, NHC Key Laboratory of Biotechnology for Microbial Drugs, State Key Laboratory of Bioactive Substances and Functions of Natural Medicines, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
Shanshan ChangCAMS Key Laboratory of Synthetic Biology For Drug Innovation, NHC Key Laboratory of Biotechnology for Microbial Drugs, State Key Laboratory of Bioactive Substances and Functions of Natural Medicines, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
Xingxing LiCAMS Key Laboratory of Synthetic Biology For Drug Innovation, NHC Key Laboratory of Biotechnology for Microbial Drugs, State Key Laboratory of Bioactive Substances and Functions of Natural Medicines, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
Yihong LiCAMS Key Laboratory of Synthetic Biology For Drug Innovation, NHC Key Laboratory of Biotechnology for Microbial Drugs, State Key Laboratory of Bioactive Substances and Functions of Natural Medicines, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
Xiaorui LiCAMS Key Laboratory of Synthetic Biology For Drug Innovation, NHC Key Laboratory of Biotechnology for Microbial Drugs, State Key Laboratory of Bioactive Substances and Functions of Natural Medicines, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
Xiumin ZhangCAMS Key Laboratory of Synthetic Biology For Drug Innovation, NHC Key Laboratory of Biotechnology for Microbial Drugs, State Key Laboratory of Bioactive Substances and Functions of Natural Medicines, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
Jiandong JiangCAMS Key Laboratory of Synthetic Biology For Drug Innovation, NHC Key Laboratory of Biotechnology for Microbial Drugs, State Key Laboratory of Bioactive Substances and Functions of Natural Medicines, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
Bin HongCAMS Key Laboratory of Synthetic Biology For Drug Innovation, NHC Key Laboratory of Biotechnology for Microbial Drugs, State Key Laboratory of Bioactive Substances and Functions of Natural Medicines, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.

Funding

Beijing Nova Program 20240484633CAMS Innovation Fund for Medical Sciences 2025-I2M-XHXX-103Fundamental and Interdisciplinary Disciplines Breakthrough Plan of the Ministry of Education of China JYB2025XDXM609Lingang Laboratory LGL-2615-07National Natural Science Foundation of China 81872780National Natural Science Foundation of China 82273832National Natural Science Foundation of China 82373771
6 · The paper itself

Abstract

Microbial sulfur-containing secondary metabolite thienodolin (1) features a unique tricyclic thieno[2,3-b]indole scaffold, yet its biosynthesis has remained enigmatic. Here, we uncover an unexpected enzymatic logic in which a consortium of distinct oxidoreductases cooperatively orchestrates indolethiophene skeleton formation and subsequent bioactivation, ultimately generating the authentic antibacterial metabolite thienoxidolin (10). Following thiotryptophan formation by SDR enzyme TndE, the heme-dependent DUF6875 enzyme TndD initiates C-S bond formation via N-hydroxylation to yield a dearomatized tricyclic species, which is efficiently driven forward and stabilized by aromatization catalyzed by the FAD-dependent oxidoreductase TndG. Notably, TndD functions as a bidirectional redox enzyme, reverting the N-hydroxyl group to the stable N-H form to complete the indolethiophene scaffold construction. After amide formation, late-stage N-hydroxylation by the cytochrome P450 enzyme TndC, previously misassigned as the C-S bond-forming enzyme, produces the bioactive product 10. Intriguingly, TndD may also mediate the deactivation of 10 back to 1, representing an intrinsic self-protection mechanism. Together, these results expand the catalytic repertoire of heme-dependent enzymes and highlight reversible N-hydroxylation as a pivotal strategy for heterocycle formation and bioactivity regulation in microbial secondary metabolism.

Indexed as

IndolesOxidoreductasesThiophenesHydroxylationIndolesOxidoreductasesThiophenesC–S bond formationcytochrome P450 TndCDUF6875 TndDN‐hydroxylationthienoxidolin

Identifiers

PMID42275295
PMCPMC13452501

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.